Sales decline 2.38% to Rs 29.56 crore
Net profit of Jenburkt Pharmaceuticals declined 16.02% to Rs 3.88 crore in the quarter ended March 2021 as against Rs 4.62 crore during the previous quarter ended March 2020. Sales declined 2.38% to Rs 29.56 crore in the quarter ended March 2021 as against Rs 30.28 crore during the previous quarter ended March 2020.For the full year,net profit rose 10.96% to Rs 16.50 crore in the year ended March 2021 as against Rs 14.87 crore during the previous year ended March 2020. Sales declined 8.07% to Rs 109.29 crore in the year ended March 2021 as against Rs 118.89 crore during the previous year ended March 2020.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content